Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Jerome G. Roncalli

Toulouse, FR 
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Toulouse, FR 
OverviewLocationsClinical Research

Overview

Jerome Roncalli practices in Toulouse, France. Mr. Roncalli is rated as an Experienced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure, Heart Attack, Cardiomyopathy, Atherectomy, and Angioplasty.

His clinical research consists of co-authoring 114 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Toulouse, France
Other Locations
Rangueuil, France
Nantes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

EXpanded CELL ENdocardiac Transplantation (EXCELLENT)
EXpanded CELL ENdocardiac Transplantation (EXCELLENT)
Enrollment Status: Completed
Publish Date: April 26, 2024
Intervention Type: Drug
Study Drugs: ProtheraCytes, Standard Treatment
Study Phase: Phase 2
Effect of Intramyocardial Mesenchymal Stem Cells Injection in Patients With Chronic Ischemic Cardiomyopathy and Left Ventricular Dysfunction Guide by NogaStar XP System Catheter.
Effect of Intramyocardial Mesenchymal Stem Cells Injection in Patients With Chronic Ischemic Cardiomyopathy and Left Ventricular Dysfunction Guide by NogaStar XP System Catheter.
Enrollment Status: Completed
Publish Date: March 30, 2023
Intervention Type: Drug
Study Drug: Autologous Mesenchymal Stem Cells from Bone Marrow
Study Phase: Phase 2
Optimisation de la Surveillance Ambulatoire Des Insuffisants CArdiaques Par Télécardiologie (OSICAT)
Optimisation de la Surveillance Ambulatoire Des Insuffisants CArdiaques Par Télécardiologie (OSICAT)
Enrollment Status: Completed
Publish Date: October 26, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

114 Total Publications

A rare single coronary artery with an anomalous origin of the left coronary artery from the posterior atrioventricular right coronary artery.
A rare single coronary artery with an anomalous origin of the left coronary artery from the posterior atrioventricular right coronary artery.
Journal: BMJ case reports
Published: August 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roncalli's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile